2021 Biopharma Update on the Novel Coronavirus: January 12
The Pharma Data
JANUARY 11, 2021
Dalcetrapib is a potential anti-viral treatment that binds to the catalytic site of 3CLMpro of SARS-CoV-2 in vitro. Centers for Disease Control and Prevention (CDC) to provide genomic sequencing of SARS-CoV-2 samples. News information is not all-inclusive and updates are published once a week on Tuesdays. . . Diagnostics.
Let's personalize your content